Profile
Full Name
Mereo BioPharma Group plcTicker Symbol
MREOExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United KingdomIPO
April 24, 2019Indexes
Not includedEmployees
36Key Details
Price
$2.33(-8.63%)
Market cap
$370.47M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.30(-50.00% YoY)
PE ratio
-
Next earnings date
May 15, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Mereo BioPharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 9, 25 Needham
BuyMar 27, 25 JP Morgan
OverweightMar 26, 25 Needham
BuyMar 18, 25 Cantor Fitzgerald
OverweightJan 13, 25 Needham
BuyDec 24, 24 LifeSci Capital
OutperformDec 17, 24 Needham
BuyDec 6, 24 Jefferies
BuyNov 12, 24 Needham
BuyOct 1, 24 Cantor Fitzgerald
OverweightInstitutional Ownership
- What is the ticker symbol for Mereo BioPharma?
- Does Mereo BioPharma pay dividends?
- What sector is Mereo BioPharma in?
- What industry is Mereo BioPharma in?
- What country is Mereo BioPharma based in?
- When did Mereo BioPharma go public?
- Is Mereo BioPharma in the S&P 500?
- Is Mereo BioPharma in the NASDAQ 100?
- Is Mereo BioPharma in the Dow Jones?
- When was Mereo BioPharma's last earnings report?
- When does Mereo BioPharma report earnings?
- Should I buy Mereo BioPharma stock now?
What is the ticker symbol for Mereo BioPharma?
The ticker symbol for Mereo BioPharma is NASDAQ:MREO
Does Mereo BioPharma pay dividends?
No, Mereo BioPharma does not pay dividends
What sector is Mereo BioPharma in?
Mereo BioPharma is in the Healthcare sector
What industry is Mereo BioPharma in?
Mereo BioPharma is in the Biotechnology industry
What country is Mereo BioPharma based in?
Mereo BioPharma is headquartered in United Kingdom
When did Mereo BioPharma go public?
Mereo BioPharma's initial public offering (IPO) was on April 24, 2019
Is Mereo BioPharma in the S&P 500?
No, Mereo BioPharma is not included in the S&P 500 index
Is Mereo BioPharma in the NASDAQ 100?
No, Mereo BioPharma is not included in the NASDAQ 100 index
Is Mereo BioPharma in the Dow Jones?
No, Mereo BioPharma is not included in the Dow Jones index
When was Mereo BioPharma's last earnings report?
Mereo BioPharma's most recent earnings report was on Mar 26, 2025
When does Mereo BioPharma report earnings?
The next expected earnings date for Mereo BioPharma is May 15, 2025
Should I buy Mereo BioPharma stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions